Concepedia

Efficacy of thoracic radiotherapy in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinomas who received and responded to tyrosine kinase inhibitor treatment

Yu‐Chun Yen, Han-Lin Hsu, Jer‐Hwa Chang, Wei-Cheng Lin, Yin-Chun Chang, Chia-Lun Chang, Jyh-Ming Chow, Kevin Sheng‐Po Yuan, Alexander T.H. Wu, Szu‐Yuan Wu

Radiotherapy and Oncology · 2018 · 40 citations · 38 references

DOI

Concepts

References

38

Validation of a combined comorbidity index

Mary E. Charlson, Ted P. Szatrowski, Janey C. Peterson et al. · Journal of Clinical Epidemiology · 1994 · 6.6K citations

, , +12

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Rafael Rosell, Enric Carcereny, Radj Gervais et al. · The Lancet Oncology · 2012 · 5.5K citations · Full text

, , +12

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

Ralph B. D’Agostino · Statistics in Medicine · 1998 · 5.4K citations

, , +16

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Caicun Zhou, Yi‐Long Wu, Gongyan Chen et al. · The Lancet Oncology · 2011 · 4.1K citations

, , +10

<i>EGFR</i> Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

Susumu Kobayashi, Titus J. Boggon, Tajhal Dayaram et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

, , +15